As the year comes to its end, December offers the perfect moment to pause, reflect, and appreciate everything we’ve achieved together.
This final chapter of 2025 brings a mix of celebration, gratitude, and excitement for what lies ahead.
From celebrating awareness and local holidays, winning new studies and attending key industry events, to securing the CTIS approvals for EU projects and expanding to new countries – here’s our 2025 wrap up.
As we welcome 2026, we send our warmest wishes for peace, joy, and success in the year ahead.
Thank you for your dedication and partnership in advancing clinical research and improving healthcare around the world.
2026 is especially meaningful for GCT as we celebrate 25 years of teamwork, growth, and shared achievements.
We look forward to continuing our commitment to excellence, delivering the highest quality, performance, and insights.
May the New Year bring bright opportunities and continued success for us all!From all of us at Global Clinical Trials
Company Growth
Austria
In August we announced our expansion to Austria, further strengthening our presence in Western Europe.
This strategic move enhances GCT’s ability to deliver high-quality clinical trial services across the DACH region and supports its ongoing commitment to operational excellence throughout Europe.
Turkey
After successful discussions in Istanbul in October and many years of close collaboration, Ascot Science joined the GCT Group of companies: ascotscience.com
Favourable regulatory timelines and a diverse patient population make Turkey an attractive destination for clinical research.
Bulgarian Office Move
A significant milestone this year was the successful relocation of our Bulgarian office.
The new space reflects our growth, expanding capabilities, and the collaborative spirit that continues to drive our work.
Industry Events
This year we proudly participated in all major conferences, strengthening our visibility, building new partnerships, and showcasing the expertise of our teams. Each event served as another step forward in our ongoing commitment to innovation, quality, and meaningful scientific contribution.
You could have met us at: AES, CTAD, CNS summit, ECNP Congress, Biotech Austria, ISCTM, ECTRIMS, AD/PD … and many other events where we strengthened existing relationships and forged new connections.
EU Leadership Meeting
Our management came together at the EU Directors’ Meeting in Istanbul, discussing ongoing projects, aligning strategic priorities, operational goals, and long-term initiatives that will shape our continued success into 2026.
Welcoming New Colleagues Globally
We were excited to welcome several new team members this year. Their diverse skills and fresh perspectives strengthen our departments and support our expanding project portfolio.
Projects
This year brought a wave of project initiations across multiple therapeutic and operational areas:
GCT involvement in these programs highlights our continued dedication to impactful, patient-focused research.
Awareness Makes a Difference
During the whole 2025, we raised awareness across multiple therapeutic areas and specific health conditions — because awareness truly makes a difference.
Looking Ahead to 2026
Thank you for your contributions, energy, and commitment throughout another successful year. December marks the end of an inspiring chapter, and together we are ready to write an even stronger one in 2026 — our 25th Anniversary year.
For a quarter of a century, GCT has been trusted by partners worldwide. We look forward to meeting you across congresses and conferences next year and celebrating this milestone together.